DiaMedica Therapeutics financials at a glance
| Year | Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2011 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.50M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-2.55 | $-0.40 | $-0.80 | $-0.74 | $-0.89 | $-0.78 | $-0.65 | $-0.52 | $-0.60 | $0.00 | ||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
2.53m | 2.93m | 3.1m | 4.11m | 5.52m | 6.37m | 11.96m | 12.01m | 18.74m | -82.55m | 26.44m | 37.95m | 0m | 37.95m |
| OCF | Operating Cash Flow |
|
$-5.46M | $-5.86M | $-4.36M | $-1.56M | $-3.02M | $-3.90M | $-5.70M | $-9.10M | $-9.19M | $-12332000.00M | $-11.51M | $-18.73M | $-3.51M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $-5.88M | $0.00M | $0.00M | $-3.03M | $-3.92M | $-7.65M | $0.00M | $-9.24M | $-12352000.00M | $-11.59M | $-18.80M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-2.26 | $-2.20 | $-1.45 | $-0.43 | $-0.64 | $-0.66 | $-0.74 | $-0.76 | $-0.59 | $-0.59 | $-0.44 | $-0.58 | $-1.59 | $0.00 |